Tuesday 11 December 2012
Personalised cancer medicine: a new strategic horizon for ESMO
The ESMO President and the ESMO Personalised Medicine Task Force Chair consider how to move from current stratified oncology to a more personalised cancer medicine by dissecting the heterogeneity of the tumours and the complexity of molecular pathways with new powerful technologies. Watch the video here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment